Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
The current Eli Lilly(LLY) stock price is $1,060.46, with a market capitalization of 1T. The stock trades at a price-to-earnings (P/E) ratio of 52.14 and offers a dividend yield of 56.9%.
As of 2025-12-18, Eli Lilly(LLY) stock has fluctuated between $1,037.00 and $1,079.26. The current price stands at $1,060.46, placing the stock +2.3% above today's low and -1.7% off the high.
Eli Lilly(LLY) shares are trading with a volume of 1.83M, against a daily average of 3.52M.
In the last year, Eli Lilly(LLY) shares hit a 52-week high of $1,111.99 and a 52-week low of $623.78.
In the last year, Eli Lilly(LLY) shares hit a 52-week high of $1,111.99 and a 52-week low of $623.78.
LLY News
Biotech and Pharma Lose Weight on Zepbound, Keep It Off With Eli Lilly’s New Pill? Data Say That Works. In this article NOVO.B LLY Eli Lilly has a new pill, cal...
These two stocks have been going in opposite directions over the past few years. Pfizer (PFE 0.04%) and Eli Lilly (LLY +2.39%) are two prominent names in healt...
Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. Claim 50% Off TipRanks Premium and Invest with Confidence Unlock hedge-fund l...
Analyst ratings
77%
of 31 ratingsMore LLY News
H.C. Wainwright notes that this morning, Eli Lilly (LLY) announced positive topline results from the Phase 3 ATTAIN-MAINTAIN trial, which the firm believes repr...
U.S. pharmaceutical company Eli Lilly & Co. (LLY) says that its new obesity pill helped patients maintain the majority of their weight loss after they switched...
Eli Lilly recently reported strong Phase 3 results for its next-generation obesity drugs, including the oral GLP‑1 pill orforglipron for weight maintenance and...
A photo illustration shows Novo Nordisk’s injectable weight-loss medication Wegovy. The company and Eli Lilly are both developing a new generation of obesity dr...
Claim 50% Off TipRanks Premium and Invest with Confidence Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper...
The company is running circles around its competition. Can anyone stop Eli Lilly (LLY +3.58%)? The pharmaceutical leader has established itself as the leader i...
Eli Lilly’s stock has beaten Nvidia’s this year, and the outperformance has been especially sharp in recent weeks. The recent rotation into healthcare stocks a...
